In 2001 the Alcor Life Extension Foundation licensed its first vitrification agent from the cryobiology research company 21st Century Medicine (21CM) to be used for
Please join Chana Phaedra as she speaks with Alcor member Larry McElhinney on his daily HealthHaven live webcast this Friday, June 13, 2008, at 12:00 p.m.
In “Philosophical Models of Immortality in Science Fiction,” (in: Immortal Engines: Life Extension and Immortality in Science Fiction and Fantasy) John Martin Fischer and Ruth
Experiments investigating the effects of medication administration via the nose are becoming increasingly common in scientific literature. Direct olfactory transport to the brain and the
Introduction In everyday or emergency medical practice, intranasal (IN) administration of therapeutic agents (i.e., drug delivery via the nose) offers several advantages over oral, intravenous,
Neuroprotective agents for stroke continue to fail in clinical trials. One important reason is that the therapeutic window for many of those agents is too
In his 1998 essay “The Failure of the Cryonics Movement” (part 1, part 2), Saul Kent stresses that cryonics has remained so unpopular because nobody
Few, if any, cryonicists today can retrace their personal interest in cryonics to Evan Cooper. Despite the broader recognition of Robert Ettinger’s book, “The Prospect
Summary The most important objective in cryonics after pronouncement of legal death is to drop metabolism as fast as possible to protect the brain and
The idea that cryonics does not involve the freezing of “dead” people but is form of low temperature care to prevent death is almost as